In the active rTMS group, the serum levels of CRP-hc and IL-2 significantly changed at week 2, and the change last through the 12 weeks period, which were not seen in the sham-rTMS group, suggesting that rTMS can change serum inflammatory cytokine levels in patients with depression. This evidence concerns the gene CRP and major depressive disorder.